Sopracordevole Francesco, Di Giuseppe Jacopo, Cervo Silvia, Buttignol Monica, Giorda Giorgio, Ciavattini Andrea, Canzonieri Vincenzo
Gynecologic Oncology Unit, Department of Surgical Oncology, CRO Aviano National Cancer Institute, Aviano, Pordenone, Italy.
Woman's Health Sciences Department, Gynaecologic Section, Polytechnic University of Marche, Ancona, Italy.
Onco Targets Ther. 2016 Jan 27;9:539-44. doi: 10.2147/OTT.S93899. eCollection 2016.
Coexistence of microinvasive squamous cell carcinoma (MISCC) and microinvasive adenocarcinoma (MIAC) of the cervix is a rare phenomenon with very few clinically significant cases described in the literature. While a conservative approach has been studied, and may be effective in MISCC, a lower number of studies that recommend conservative treatment are available for MIAC. We report two cases of synchronous cervix lesions in two separate foci, MISCC and MIAC, who underwent fertility-sparing treatment with long-term follow-up. We describe clinical, histological, and immunohistochemical features of the two cases. The first case is a 41-year-old female with a diagnosis of MIAC of endocervical type, grade 1 differentiation, with a stromal invasion, associated with a separate area of squamous cell carcinoma (International Federation of Gynecology and Obstetrics/TNM stage: pT1a1G1). The second case is a 45-year-old female with a diagnosis of plurifocal MISCC, associated with an MIAC of endocervical type with a stromal invasion (International Federation of Gynecology and Obstetrics/TNM stage: pT1a1G1). After multidisciplinary counseling, both patients accepted conization as definitive treatment. Eleven years after the conization, all tests (Papanicolaou smear, colposcopy, cervical curettage, and hybrid capture 2-human papillomavirus test) planned quarterly in the first year and every 6 months in the subsequent years were negative in both patients. In women affected by stage IA1 squamous cervical cancer coexisting with stage IA1 adenocarcinoma endocervical type, with clear margins, and without lymphovascular space invasion, cervical conization may be considered a fertility-preserving, safe, and definitive therapeutic option.
宫颈微浸润性鳞状细胞癌(MISCC)和微浸润性腺癌(MIAC)并存是一种罕见现象,文献中描述的具有临床意义的病例极少。虽然已经对保守治疗方法进行了研究,且其对MISCC可能有效,但推荐用于MIAC保守治疗的研究较少。我们报告了两例分别位于两个不同病灶的同步宫颈病变病例,即MISCC和MIAC,她们均接受了保留生育功能的治疗并进行了长期随访。我们描述了这两例病例的临床、组织学和免疫组化特征。第一例是一名41岁女性,诊断为宫颈管型MIAC,1级分化,伴有间质浸润,同时存在一个单独的鳞状细胞癌区域(国际妇产科联盟/ TNM分期:pT1a1G1)。第二例是一名45岁女性,诊断为多灶性MISCC,伴有宫颈管型MIAC和间质浸润(国际妇产科联盟/ TNM分期:pT1a1G1)。经过多学科会诊,两名患者均接受了锥形切除术作为确定性治疗。锥形切除术后11年,两名患者在第一年每季度计划进行的所有检查(巴氏涂片、阴道镜检查、宫颈刮除术和杂交捕获2人乳头瘤病毒检测)以及随后几年每6个月进行的检查均为阴性。对于患有IA1期鳞状宫颈癌并同时存在IA1期宫颈管型腺癌、切缘清晰且无脉管间隙浸润的女性,宫颈锥形切除术可被视为一种保留生育功能、安全且确定性的治疗选择。